NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
The VITA-FAST tokens have been met with overwhelming interest
The company is already marketing the 4 mg and 10 mg strengths
Convergent action on AMR identified as an important area of intervention
Subscribe To Our Newsletter & Stay Updated
